CYP2D6 Haplotype Determination Using Long Range Allele-Specific Amplification: Resolution of a Complex Genotype and a Discordant Genotype Involving the CYP2D6∗59 Allele

Journal of Molecular Diagnostics

Volumn 17, Issue 6, 2015, Pages 740-748

  Gaedigk, Andrea ^a,b   Riffel, Amanda K ^a   Leeder, J Steven ^a,b  

^a Division of Clinical Pharmacology   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2D6;

ALLELE; ARTICLE; BINDING SITE; CHROMOSOME; CONTROLLED STUDY; COPY NUMBER VARIATION; FEMALE; GENE AMPLIFICATION; GENE DUPLICATION; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; MULTIPLEX POLYMERASE CHAIN REACTION; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; GENETICS; POLYMERASE CHAIN REACTION; PROCEDURES;

ALLELES; CYTOCHROME P-450 CYP2D6; HAPLOTYPES; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84943611363     PISSN: 15251578     EISSN: 19437811     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2015.06.007     Document Type: Article

References (30)

1. S.F. Zhou Polymorphism of human cytochrome P450 2D6 and its clinical significance: part I Clin Pharmacokinet 48 2009 689 723
2. S.F. Zhou Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II Clin Pharmacokinet 48 2009 761 804
3. S.C. Sim, and M. Ingelman-Sundberg Update on Allele Nomenclature for Human Cytochromes P450 and the Human Cytochrome P450 Allele (CYP-Allele) Nomenclature Database Methods Mol Biol 987 2013 251 259
4. L.K. Teh, and L. Bertilsson Pharmacogenomics of CYP2D6: molecular genetics, interethnic differences and clinical importance Drug Metab Pharmacokinet 27 2012 55 67
5. U.M. Zanger, S. Raimundo, and M. Eichelbaum Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry Naunyn Schmiedebergs Arch Pharmacol 369 2004 23 37
6. U.M. Zanger, and M. Schwab Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation Pharmacol Ther 138 2013 103 141
7. U.M. Zanger, M. Turpeinen, K. Klein, and M. Schwab Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation Anal Bioanal Chem 392 2008 1093 1108
8. D.J. Muller, I. Kekin, A.C. Kao, and E.J. Brandl Towards the implementation of CYP2D6 and CYP2C19 genotypes in clinical practice: update and report from a pharmacogenetic service clinic Int Rev Psychiatry 25 2013 554 571
9. K.R. Gardner, F.X. Brennan, R. Scott, and J. Lombard The potential utility of pharmacogenetic testing in psychiatry Psychiatry J 2014 2014 730956
10. K.R. Crews, A. Gaedigk, H.M. Dunnenberger, J.S. Leeder, T.E. Klein, K.E. Caudle, C.E. Haidar, D.D. Shen, J.T. Callaghan, S. Sadhasivam, C.A. Prows, E.D. Kharasch, and T.C. Skaar Clinical Pharmacogenetics Implementation C: Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update Clin Pharmacol Ther 95 2014 376 382
11. J.K. Hicks, J.J. Swen, C.F. Thorn, K. Sangkuhl, E.D. Kharasch, V.L. Ellingrod, T.C. Skaar, D.J. Muller, A. Gaedigk, J.C. Stingl Clinical Pharmacogenetics Implementation Consortium Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants Clin Pharmacol Ther 93 2013 402 408
12. A. Gaedigk Complexities of CYP2D6 gene analysis and interpretation Int Rev Psychiatry 25 2013 534 553
13. J.K. Hicks, J.J. Swen, and A. Gaedigk Challenges in CYP2D6 phenotype assignment from genotype data: a critical assessment and call for standardization Curr Drug Metab 15 2014 218 235
14. A. Gaedigk, L.D. Bradford, S.W. Alander, and J.S. Leeder CYP2D6∗36 gene arrangements within the CYP2D6 locus: association of CYP2D6∗36 with poor metabolizer status Drug Metab Dispos 34 2006 563 569
15. S.A. Scott, Q. Tan, U. Baber, Y. Yang, S. Martis, J. Bander, R. Kornreich, J.S. Hulot, and R.J. Desnick An allele-specific PCR system for rapid detection and discrimination of the CYP2C19∗4A,∗4B, and∗17 alleles: implications for clopidogrel response testing J Mol Diagn 15 2013 783 789
16. A. Gaedigk, L. Ndjountche, R. Gaedigk, J.S. Leeder, and L.D. Bradford Discovery of a novel nonfunctional cytochrome P450 2D6 allele, CYP2D∗42, in African American subjects Clin Pharmacol Ther 73 2003 575 576
17. A. Gaedigk, A. Bhathena, L. Ndjountche, R.E. Pearce, S.M. Abdel-Rahman, S.W. Alander, L.D. Bradford, P.K. Rogan, and J.S. Leeder Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans Pharmacogenomics J 5 2005 173 182
18. A. Gaedigk, J.D. Eklund, R.E. Pearce, J.S. Leeder, S.W. Alander, M.S. Phillips, L.D. Bradford, and M.J. Kennedy Identification and characterization of CYP2D6∗56B, an allele associated with the poor metabolizer phenotype Clin Pharmacol Ther 81 2007 817 820
19. A. Gaedigk, M. Isidoro-Garcia, R.E. Pearce, S. Sanchez, V. Garcia-Solaesa, C. Lorenzo-Romo, G. Gonzalez-Tejera, and S. Corey Discovery of the nonfunctional CYP2D6∗31 allele in Spanish, Puerto Rican, and US Hispanic populations Eur J Clin Pharmacol 66 2010 859 864
20. A. Gaedigk, D. Frank, and U. Fuhr Identification of a novel non-functional CYP2D6 allele, CYP2D6∗69, in a Caucasian poor metabolizer individual Eur J Clin Pharmacol 65 2009 97 100
21. A. Gaedigk, L. Ndjountche, K. Divakaran, L. Dianne Bradford, I. Zineh, T.F. Oberlander, D.C. Brousseau, D.G. McCarver, J.A. Johnson, S.W. Alander, K. Wayne Riggs, and J. Steven Leeder Cytochrome P4502D6 (CYP2D6) gene locus heterogeneity: characterization of gene duplication events Clin Pharmacol Ther 81 2007 242 251
22. A. Gaedigk, L.K. Montane Jaime, J.S. Bertino Jr., A. Berard, V.M. Pratt, L.D. Bradfordand, and J.S. Leeder Identification of novel CYP2D7-2D6 hybrids: non-functional and functional variants Front Pharmacol 1 2010 121
23. A. Gaedigk, U. Fuhr, C. Johnson, L.A. Berard, D. Bradford, and J.S. Leeder CYP2D7-2D6 hybrid tandems: identification of novel CYP2D6 duplication arrangements and implications for phenotype prediction Pharmacogenomics 11 2010 43 53
24. A. Gaedigk, G.P. Twist, and J.S. Leeder CYP2D6, SULT1A1 and UGT2B17 copy number variation: quantitative detection by multiplex PCR Pharmacogenomics 13 2012 91 111
25. C. Toscano, S. Raimundo, K. Klein, M. Eichelbaum, M. Schwab, and U.M. Zanger A silent mutation (2939G>A, exon 6; CYP2D6∗59) leading to impaired expression and function of CYP2D6 Pharmacogenet Genomics 16 2006 767 770
26. A. Gaedigk, S.D. Simon, R.E. Pearce, L.D. Bradford, M.J. Kennedy, and J.S. Leeder The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype Clin Pharmacol Ther 83 2008 234 242
27. A. Gaedigk, C. Garcia-Ribera, H.E. Jeong, J.G. Shin, and J.T. Hernandez-Sanchez Resolution of a clinical AmpliChip CYP450 Test no call: discovery and characterization of novel CYP2D6∗1 haplotypes Pharmacogenomics 15 2014 1175 1184
28. A. Gaedigk, N. Freeman, T. Hartshorne, A.K. Riffel, D. Irwin, J.R. Bishop, M.A. Stein, J.H. Newcorn, L.K.M. Jaime, M. Cherner, and J.S. Leeder SNP genotyping using TaqMan® technology: the CYP2D6∗17 assay conundrum Sci Rep 5 2015 9257
29. R. Stadhouders, S.D. Pas, J. Anber, J. Voermans, T.H.M. Mes, and M. Schutten The effect of primer-template mismatches on the detection and quantification of nucleic acids using the 5′ nuclease assay J Mol Diagn 12 2010 109 117
30. J.K. Hicks, J.R. Bishop, K. Sangkuhl, D.J. Muller, Y. Ji, S.G. Leckband, J.S. Leeder, R.L. Graham, D.L. Chiulli, A. LLerena, T.C. Skaar, S.A. Scott, J.C. Stingl, T.E. Klein, K.E. Caudle, and A. Gaedigk Clinical Pharmacogenetics Implementation Consortium (CPIC) guildeline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors Clin Pharmacol Ther 98 2015 127 134